Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong · Delayed Price · Currency is HKD 56.15
+5.45 (10.75%)
At close: Jan 21, 2026
HKG:6609 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 334.94 | 277.9 | 232.34 | 183.03 | 90.09 | 14.56 | Upgrade | |
Revenue Growth (YoY) | 33.31% | 19.61% | 26.94% | 103.17% | 518.66% | - | Upgrade |
Cost of Revenue | 116.96 | 104.24 | 80.55 | 59.15 | 35.14 | 7.48 | Upgrade |
Gross Profit | 217.98 | 173.66 | 151.79 | 123.88 | 54.95 | 7.09 | Upgrade |
Selling, General & Admin | 149.01 | 137.81 | 153.88 | 167.99 | 135.01 | 156.15 | Upgrade |
Research & Development | 47.81 | 58.94 | 123.83 | 153.69 | 76.31 | 51.13 | Upgrade |
Other Operating Expenses | 21.45 | 10.26 | 0.95 | 1.82 | 3.21 | 1.02 | Upgrade |
Operating Expenses | 218.27 | 207 | 278.66 | 323.5 | 214.53 | 208.3 | Upgrade |
Operating Income | -0.29 | -33.34 | -126.87 | -199.62 | -159.58 | -201.21 | Upgrade |
Interest Expense | -1.99 | -1.75 | -2.16 | -2.15 | -2.36 | -1.6 | Upgrade |
Interest & Investment Income | 7.75 | 8.77 | 11.2 | 15.14 | 5.5 | 0.17 | Upgrade |
Earnings From Equity Investments | - | - | - | -34.8 | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.77 | 1.17 | 1.4 | 8.3 | -22.28 | -7.59 | Upgrade |
Other Non Operating Income (Expenses) | 11.52 | 8.79 | 11.21 | 11.88 | -23.02 | -6.15 | Upgrade |
EBT Excluding Unusual Items | 17.75 | -16.36 | -105.22 | -201.25 | -201.74 | -216.37 | Upgrade |
Gain (Loss) on Sale of Investments | 21.74 | 4.37 | 0.93 | - | 3.84 | 0.19 | Upgrade |
Gain (Loss) on Sale of Assets | 0.73 | - | 1.37 | - | - | - | Upgrade |
Pretax Income | 40.22 | -11.99 | -102.92 | -201.25 | -197.91 | -216.18 | Upgrade |
Income Tax Expense | -2.22 | 1.63 | -8.91 | -0.87 | - | - | Upgrade |
Earnings From Continuing Operations | 42.44 | -13.62 | -94.01 | -200.38 | -197.91 | -216.18 | Upgrade |
Minority Interest in Earnings | - | - | - | - | 3.68 | 2.52 | Upgrade |
Net Income | 42.44 | -13.62 | -94.01 | -200.38 | -194.23 | -213.66 | Upgrade |
Net Income to Common | 42.44 | -13.62 | -94.01 | -200.38 | -194.23 | -213.66 | Upgrade |
Shares Outstanding (Basic) | 38 | 38 | 38 | 38 | 33 | 22 | Upgrade |
Shares Outstanding (Diluted) | 38 | 38 | 38 | 38 | 33 | 22 | Upgrade |
Shares Change (YoY) | 0.72% | -0.81% | -0.51% | 14.60% | 52.84% | 16.35% | Upgrade |
EPS (Basic) | 1.12 | -0.36 | -2.47 | -5.24 | -5.82 | -9.78 | Upgrade |
EPS (Diluted) | 1.12 | -0.36 | -2.47 | -5.24 | -5.82 | -9.78 | Upgrade |
Free Cash Flow | 30.56 | -7.27 | -92.98 | -303.28 | -258.69 | -90.42 | Upgrade |
Free Cash Flow Per Share | 0.80 | -0.19 | -2.44 | -7.92 | -7.75 | -4.14 | Upgrade |
Gross Margin | 65.08% | 62.49% | 65.33% | 67.68% | 60.99% | 48.67% | Upgrade |
Operating Margin | -0.09% | -12.00% | -54.60% | -109.06% | -177.13% | -1381.74% | Upgrade |
Profit Margin | 12.67% | -4.90% | -40.46% | -109.48% | -215.59% | -1467.27% | Upgrade |
Free Cash Flow Margin | 9.12% | -2.62% | -40.02% | -165.70% | -287.14% | -620.92% | Upgrade |
EBITDA | 21.27 | -9.87 | -102.57 | -173.68 | -152.15 | -196.26 | Upgrade |
EBITDA Margin | 6.35% | -3.55% | -44.14% | -94.89% | -168.88% | - | Upgrade |
D&A For EBITDA | 21.56 | 23.47 | 24.3 | 25.94 | 7.43 | 4.95 | Upgrade |
EBIT | -0.29 | -33.34 | -126.87 | -199.62 | -159.58 | -201.21 | Upgrade |
EBIT Margin | -0.09% | -12.00% | -54.60% | -109.06% | -177.13% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.